Association between Anti-Hepatitis C Viral Intervention Therapy and Risk of Sjögren’s Syndrome: A National Retrospective Analysis

Hepatitis C virus (HCV) infection is a potential risk factor for Sjögren’s syndrome (SS). However, it is unclear whether anti-HCV intervention therapy could decrease SS risk. A retrospective cohort analysis from 1997–2012 comprising 17,166 eligible HCV-infected adults was conducted. By 1:2 propensit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tung, Chien-Hsueh, Chen, Yen-Chun, Chen, Yi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332495/
https://www.ncbi.nlm.nih.gov/pubmed/35893350
http://dx.doi.org/10.3390/jcm11154259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332495/
https://www.ncbi.nlm.nih.gov/pubmed/35893350
http://dx.doi.org/10.3390/jcm11154259

Ejemplares similares